McKesson Ventures helps innovators build and scale businesses that will lead to stronger, more sustainable future for health care. We partner with companies that are enabling and driving positive change while pursuing high-growth opportunities.
Ashley is responsible for deal sourcing, diligence, and supporting portfolio management. She brings nearly a decade of experience working with innovative healthcare services and technology companies as an investor and operator. Before joining McKesson Ventures, Ashley was at IBM Watson Health in New York, where she focused on commercializing emerging cognitive technologies in new markets. Prior to that, Ashley was at Sterling Partners, a middle-market private equity firm, where she focused on investing in healthcare services businesses. Ashley began her career in investment banking at Deutsche Bank. Ashley received her BS from the University of Illinois Urbana-Champaign and MBA from Harvard Business School.
Carrie brings nearly 15 years of healthcare experience from several vantage points within the healthcare industry. Prior to joining McKesson Ventures, she served as Vice President, Strategy and Business Development for San Francisco-based digital therapeutics pioneer Omada Health, whose mission is tied to reducing the risk for obesity related chronic disease. Prior to Omada, Carrie held roles within McKesson’s Strategy & Business Development team, working to advance strategies aimed at innovation within hospital pharmacy and clinical trial patient recruitment. She began her career in drug development, where she managed oncology clinical trials in both large pharmaceutical and biotech settings. Williams holds a Master of Business Administration from the Haas School of Business at the University of California at Berkeley and earned her undergraduate degree in biology from the University of Massachusetts Amherst. Originally from Boston, she now calls San Francisco home, where she lives with her husband, daughter, and their golden retriever, Fenway. You can take a girl out of Boston, but she’ll always love the Sox.
Dave Schulte is a Managing Director and co-leads McKesson Ventures investing efforts. Previously, he helped grow Kaiser Permanente Ventures from $20M to $400M of assets and managed the investment team. His investments include: Landmark Health (acquired by General Atlantic), SHYFT Analytics (acquired by Medidata), Komodo Health, Aledade, Infusion Express, Omada Health, Proteus Digital Health, Ingenious Med, MetricStream, Pulmonx, AtheroMed (acquired by Phillips) and Torax Medical (acquired by J&J). Dave is a member of: the Harvard Kennedy School Health Policy Leadership Council, the Boehringer Ingelheim Digital Health Advisory Council, the Aspen Institute Society of Fellows and the St. John’s University Private Investment Fund. He is a graduate of St. John’s University and earned a Master of Public Policy from Harvard Kennedy School. Dave grew up in Minneapolis, where he was an all-state soccer and all-conference basketball player. Now he aspires to “all-backyard” in the eyes of his children.
Giselle Erazo is the Executive Assistant to Tom Rodgers and Dave Schulte as well as the office manager for the team. Giselle plays an integral role in managing the day-to-day operations for McKesson Ventures by creating a delightful and hassle-free experience for all guests. She brings over 15 years of experience as an executive assistant and office manager. Giselle has been with McKesson for over 10 years and previously worked in McKesson’s General Counsel Organization and other industries, including venture capital, investment banking and international infrastructure. Giselle is a Bay Area native and lives with her daughter and dog, who thinks he is tough but is the sweetest being at heart. She also enjoys live music, being outdoors and exploring places near and far.
Jennifer Carter is the Vice President of Portfolio Development for McKesson Ventures. Jennifer works closely with portfolio companies to help identify and evaluate synergies across the McKesson ecosystem, which includes McKesson’s business units, customers and employee base. In addition, when these synergies create mutual value she helps facilitate efficient execution by acting as a liaison or project manager in order to ensure McKesson Ventures lives up to its value proposition. Jennifer brings over 15 years of experience from various roles across the McKesson enterprise. Jennifer holds a B.S. in Economics from Boston College. Although born and raised in San Francisco, Jennifer spends harvest season on the family farm cultivating pluots and disrupting the plum and apricot industries.
Mark Padilla is lead counsel for McKesson Ventures. In addition to his role with McKesson Ventures, he is Chief Counsel, Corporate and Securities for McKesson Corporation. In addition, Padilla is principal counsel to the corporation’s Treasury department and works on mergers and acquisitions (M&A) transactions. Previously Padilla spent a decade at Wilson Sonsini Goodrich & Rosati in Palo Alto, CA, representing information technology and life sciences startups in venture capital financings, M&A transactions and IPOs. He also represented public companies, advising them on SEC public disclosure and securities transactions. He possesses a J.D. from the Georgetown University Law Center, a B.A. from Yale University and an undying love of the Los Angeles Lakers.
McKesson is one of the newest recruits for Guide Dogs for the Blind. He is a yellow male Labrador retriever, born on March 10, 2017. He just left campus a week ago to spend the next year with his puppy raisers in Snohomish, Washington. He was named in honor of McKesson Ventures’ recent donation to GDB. Photo credit: Guide Dogs for the Blind.
